# Geron Corp: filings

GERN · Nasdaq · CIK 886744 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gern.md) · [Financials](/companies/gern/financials.md) · [Filings](/companies/gern/filings.md) · [Insiders](/companies/gern/insiders.md)

## Reports and events: 338 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 474, 8-K 240, 10-Q 53, SC 13G/A 34, 3 33, DEFA14A 20, 424B5 19, 10-K 18, DEF 14A 18, 5 15, EFFECT 15, S-3 15, S-8 15, SC 13G 13, CORRESP 11, UPLOAD 11, 144 8, CT ORDER 8, SCHEDULE 13G/A 8, ARS 6, 4/A 4, PRE 14A 4, 8-K/A 3, S-3/A 3, SC 13D/A 3, 3/A 2, 424B2 2, FWP 2, S-3ASR 2, S-3MEF 2, SC 13D 2, SCHEDULE 13G 2, SEC STAFF LETTER 2, 10-K/A 1, DEFR14A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 10:05 ET | [8-K](/filings/0001193125-26-336508.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-336508 |
| 2026-08-05 | 20:41 ET | [10-Q](/filings/0000886744-26-000037.md) | Quarterly report, period 2026-06-30 | 0000886744-26-000037 |
| 2026-05-27 | 20:01 ET | [8-K](/filings/0001193125-26-241842.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-241842 |
| 2026-05-06 | 20:49 ET | [10-Q](/filings/0000886744-26-000032.md) | Quarterly report, period 2026-03-31 | 0000886744-26-000032 |
| 2026-04-07 | 20:30 ET | [DEF 14A](/filings/0000886744-26-000024.md) | Proxy statement, period 2026-05-20 | 0000886744-26-000024 |
| 2026-03-26 | 12:18 ET | [8-K](/filings/0001193125-26-125151.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-125151 |
| 2026-03-02 | 12:11 ET | [10-K](/filings/0000886744-26-000008.md) | Annual report, period 2025-12-31 | 0000886744-26-000008 |
| 2026-02-25 | 12:15 ET | [8-K](/filings/0001193125-26-068523.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-068523 |
| 2026-01-12 | 13:00 ET | [8-K](/filings/0000886744-26-000003.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000886744-26-000003 |
| 2026-01-06 | 11:01 ET | [8-K](/filings/0001193125-26-003388.md) | 1.01 Entry into a material agreement | 0001193125-26-003388 |
| 2025-12-16 | 21:01 ET | [8-K](/filings/0000886744-25-000074.md) | 2.05 Exit or disposal costs | 0000886744-25-000074 |
| 2025-11-07 | 21:11 ET | [10-Q](/filings/0000886744-25-000071.md) | Quarterly report, period 2025-09-30 | 0000886744-25-000071 |
| 2025-11-05 | 12:06 ET | [8-K](/filings/0000886744-25-000068.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000886744-25-000068 |
| 2025-10-14 | 12:16 ET | [8-K](/filings/0001628280-25-044862.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-044862 |
| 2025-08-06 | 20:16 ET | [8-K](/filings/0000886744-25-000054.md) | 5.02 Departure or appointment of officers or directors | 0000886744-25-000054 |
| 2025-08-06 | 20:11 ET | [10-Q](/filings/0000886744-25-000052.md) | Quarterly report, period 2025-06-30 | 0000886744-25-000052 |
| 2025-08-06 | 11:10 ET | [8-K](/filings/0000886744-25-000048.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000886744-25-000048 |
| 2025-05-27 | 20:26 ET | [8-K](/filings/0000886744-25-000032.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000886744-25-000032 |
| 2025-05-07 | 20:06 ET | [10-Q](/filings/0000886744-25-000010.md) | Quarterly report, period 2025-03-31 | 0000886744-25-000010 |
| 2025-05-07 | 11:05 ET | [8-K](/filings/0000886744-25-000007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000886744-25-000007 |
| 2025-04-08 | 20:06 ET | [DEF 14A](/filings/0001140361-25-012825.md) | Proxy statement, period 2025-05-21 | 0001140361-25-012825 |
| 2025-03-17 | 20:10 ET | [8-K/A](/filings/0000950170-25-040247.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-040247 |
| 2025-03-11 | 20:54 ET | [8-K](/filings/0000950170-25-037260.md) | 5.02 Departure or appointment of officers or directors | 0000950170-25-037260 |
| 2025-02-27 | 22:33 ET | [10-K](/filings/0000950170-25-027982.md) | Annual report, period 2024-12-31 | 0000950170-25-027982 |
| 2025-02-26 | 12:45 ET | [8-K](/filings/0000950170-25-027331.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-027331 |
| 2025-01-13 | 13:05 ET | [8-K](/filings/0000950170-25-004579.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-004579 |
| 2024-11-07 | 21:05 ET | [10-Q](/filings/0000950170-24-123282.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123282 |
| 2024-11-07 | 12:05 ET | [8-K](/filings/0000950170-24-122771.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-122771 |
| 2024-08-08 | 20:10 ET | [10-Q](/filings/0000950170-24-093950.md) | Quarterly report, period 2024-06-30 | 0000950170-24-093950 |
| 2024-08-08 | 11:10 ET | [8-K](/filings/0000950170-24-093307.md) | 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093307 |
| 2024-06-07 | 20:03 ET | [8-K](/filings/0000950170-24-070574.md) | 8.01 Other events | 0000950170-24-070574 |
| 2024-05-13 | 20:05 ET | [8-K](/filings/0000950170-24-058622.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-058622 |
| 2024-05-02 | 20:05 ET | [10-Q](/filings/0000950170-24-052074.md) | Quarterly report, period 2024-03-31 | 0000950170-24-052074 |
| 2024-05-02 | 11:09 ET | [8-K](/filings/0000950170-24-051565.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-051565 |
| 2024-03-27 | 20:51 ET | [DEF 14A](/filings/0001140361-24-015662.md) | Proxy statement, period 2024-05-09 | 0001140361-24-015662 |
| 2024-03-20 | 01:32 ET | [8-K](/filings/0000950170-24-033921.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-033921 |
| 2024-03-19 | 10:30 ET | [8-K](/filings/0000950170-24-033142.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-033142 |
| 2024-03-14 | 20:08 ET | [8-K](/filings/0000950170-24-031475.md) | 8.01 Other events | 0000950170-24-031475 |
| 2024-02-28 | 21:05 ET | [10-K](/filings/0000950170-24-022056.md) | Annual report, period 2023-12-31 | 0000950170-24-022056 |
| 2024-02-28 | 12:20 ET | [8-K](/filings/0000950170-24-021658.md) | 2.02 Results of operations | 0000950170-24-021658 |
| 2024-01-30 | 13:00 ET | [8-K](/filings/0000950170-24-008536.md) | 8.01 Other events | 0000950170-24-008536 |
| 2024-01-08 | 13:25 ET | [8-K](/filings/0000950170-24-002722.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-002722 |
| 2023-12-15 | 21:23 ET | [8-K](/filings/0000950170-23-070765.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws | 0000950170-23-070765 |
| 2023-11-28 | 21:05 ET | [8-K](/filings/0000950170-23-066396.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-066396 |
| 2023-11-02 | 12:50 ET | [8-K](/filings/0000950170-23-057772.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-057772 |
| 2023-11-02 | 12:03 ET | [10-Q](/filings/0000950170-23-057760.md) | Quarterly report, period 2023-09-30 | 0000950170-23-057760 |
| 2023-09-29 | 13:02 ET | [8-K](/filings/0000950170-23-050580.md) | 8.01 Other events | 0000950170-23-050580 |
| 2023-09-12 | 01:01 ET | [8-K](/filings/0000950170-23-047555.md) | 5.02 Departure or appointment of officers or directors | 0000950170-23-047555 |
| 2023-08-22 | 20:59 ET | [8-K](/filings/0000950170-23-043949.md) | 8.01 Other events | 0000950170-23-043949 |
| 2023-08-03 | 20:24 ET | [8-K](/filings/0000950170-23-038061.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-038061 |

Page 1 of 7. [Older](/companies/gern/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:59 ET. No prices; not investment advice.